Recurrent Aggressive Angiomyxoma That Responded to the Gonadotropin-Releasing Hormone (GnRH) Antagonist Relugolix

Arisa Saito; Shinichi Komiyama; Masaru Nagashima; Tsuyoki Kugimiya; Takahumi Mukai

doi:10.7759/cureus.81270

journal article Mar 27, 2025

Recurrent Aggressive Angiomyxoma That Responded to the Gonadotropin-Releasing Hormone (GnRH) Antagonist Relugolix

Arisa Saito Shinichi Komiyama

Masaru Nagashima Tsuyoki Kugimiya Takahumi Mukai

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.81270

Topics

No keywords indexed for this article. Browse by subject →

References

15

[1]

Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum: report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol. 1983, 7:463-75. 10.1097/00000478-198307000-00009 10.1097/00000478-198307000-00009

[2]

Bagga R, Keepanasseril A, Suri V, Nijhawan R. Aggressive angiomyxoma of the vulva in pregnancy: a case report and review of management options. MedGenMed. 2007, 9:16.

[3]

Wang Y, Bu X, Liu Y, Xing Y, Tong Q. Characteristics and treatment strategies of aggressive angiomyxoma in women: a retrospective review of 87 cases. Front Surg. 2023, 10:966971. 10.3389/fsurg.2023.966971 10.3389/fsurg.2023.966971

[4]

Chan YM, Hon E, Ngai SW, Ng TY, Wong LC. Aggressive angiomyxoma in females: is radical resection the only option?. Acta Obstet Gynecol Scand. 2000, 79:216-20.

[5]

Xu H, Sun P, Xu R, Wang L, Shi Y. Aggressive angiomyxoma in pregnancy: a case report and literature review. J Int Med Res. 2020, 48:300060520936414. 10.1177/0300060520936414 10.1177/0300060520936414

[6]

Outwater EK, Marchetto BE, Wagner BJ, Siegelman ES. Aggressive angiomyxoma: findings on CT and MR imaging. AJR Am J Roentgenol. 1999, 172:435-8. 10.2214/ajr.172.2.9930798 10.2214/ajr.172.2.9930798

[7]

McCluggage WG, Patterson A, Maxwell P. Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity. J Clin Pathol. 2000, 53:603-5. 10.1136/jcp.53.8.603 10.1136/jcp.53.8.603

[8]

Alomary NA, Albeeshi MZ, Al Thebaity RE, Yousef ZM, El-Boghdadly SA. Aggressive angiomyxoma persistently misdiagnosed as an obturator hernia managed with resection and hormonal therapy: case report. J Surg Case Rep. 2020, 2020:rjaa330. 10.1093/jscr/rjaa330 10.1093/jscr/rjaa330

[9]

Fine BA, Munoz AK, Litz CE, Gershenson DM. Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist. Gynecol Oncol. 2001, 81:120-2. 10.1006/gyno.2000.6119 10.1006/gyno.2000.6119

[10]

Fucà G, Hindi N, Ray-Coquard I, et al.. Treatment outcomes and sensitivity to hormone therapy of aggressive angiomyxoma: a multicenter, international, retrospective study. Oncologist. 2019, 24:e536-41. 10.1634/theoncologist.2018-0338 10.1634/theoncologist.2018-0338

[11]

Gay F, Champigneulle J, Tortuyaux JM, Cuny T, Régent D, Laurent-Croisé V. Aggressive angiomyxoma. Diagn Interv Imaging. 2013, 94:657-61. 10.1016/j.diii.2013.01.009 10.1016/j.diii.2013.01.009

[12]

Hajjar R, Alharthi M, Richard C, Gougeon F, Loungnarath R. Pelvic aggressive angiomyxoma: major challenges in diagnosis and treatment. Cureus. 2019, 11:e4419. 10.7759/cureus.4419 10.7759/cureus.4419

[13]

Shinohara N, Nonomura K, Ishikawa S, Seki H, Koyanagi T. Medical management of recurrent aggressive angiomyxoma with gonadotropin-releasing hormone agonist. Int J Urol. 2004, 11:432-5. 10.1111/j.1442-2042.2004.00816.x 10.1111/j.1442-2042.2004.00816.x

[14]

Osuga Y, Enya K, Kudou K, Tanimoto M, Hoshiai H. Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injection for uterine leiomyomas: a randomizes controlled trial. Obstet Gynecol. 2019, 133:423-33. 10.1097/AOG.0000000000003141 10.1097/aog.0000000000003141

[15]

Watts NB, Binkley N, Owens CD, et al.. Bone mineral density changes associated with pregnancy, lactation, and medical treatments in premenopausal women and effects later in life. J Womens Health (Larchmt). 2021, 30:1416-30. 10.1089/jwh.2020.8989 10.1089/jwh.2020.8989

Metrics

1

Citations

15

References

Details

Published: Mar 27, 2025

Authors

Cite This Article

Arisa Saito, Shinichi Komiyama, Masaru Nagashima, et al. (2025). Recurrent Aggressive Angiomyxoma That Responded to the Gonadotropin-Releasing Hormone (GnRH) Antagonist Relugolix. Cureus. https://doi.org/10.7759/cureus.81270

Recurrent Aggressive Angiomyxoma That Responded to the Gonadotropin-Releasing Hormone (GnRH) Antagonist Relugolix

You May Also Like